ANTX
#3736
AN2 Therapeutics, Inc. - Common Stock
4.7 8 USD
+0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+5.05%
Variación mensual
+0.84%
Variación en los últimos 6 meses
+254.07%
Cambio anual
+342.59%
Cierres anteriores
4.5 5
Open
4.6 7
Mínimo
4.6 3
High
4.9 0
Volumen
741
Financials
- Market Capitalization 172.16 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3731 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.23 USD | -7.52% | -2.38% | +6.03% | -15.75% | 148.22 M USD | ||
| 3734 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 9.03 USD | -0.11% | -3.73% | +8.66% | -45.60% | 167.31 M USD | ||
| 3744 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.82 USD | +1.68% | -0.55% | +0.55% | +6.43% | 170.57 M USD | ||
| 3749 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 3.99 USD | +0.76% | -7.21% | +2.84% | +88.21% | 163.30 M USD |